The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Long-Term Effects and Clinical Burden Associated with Immune Checkpoint Inhibitor Toxicities in Cancer Patients

  • By

  • Veera Nurmela

  • Anni Juntunen

  • Satu Tiainen

  • Janne Martikainen

  • Sanna Pasonen-Seppänen

  • Aino Rönkä

  • June 23, 2026

Share

Original Source(s)

The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer

  • by Veera Nurmela, Anni Juntunen, Satu Tiainen, Janne Martikainen, Sanna Pasonen-Seppänen, Aino Rönkä

  • June 23, 2026

Related Content

Beyond classical boundaries: rethinking ICU access in acute leukemia

Intraoperative Evaluation of Sarcoma Surgical Margins With Indocyanine Green Fluorescence Imaging: Results From an Observational Study

Safety-Oriented Benchmarking of Large Language Models in Risk-Based Management of Abnormal Cervical Screening Results: Scenario-Based Benchmark Study